FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Cybersecurity Alert Issued for Medtronic Cardiac Devices

FDA issues a safety alert about cybersecurity vulnerabilities identified in wireless telemetry technology used for communication between Medtronics im...

Human Drugs

Draft Guide on Rare Disease Natural History Studies

FDA makes available a draft guide entitled Rare Diseases: Natural History Studies for Drug Development.

Medical Devices

Genetesis Cardia Imaging Platform Cleared

FDA clears a Genetesis 510(k) clearance for its cardiac imaging platform, which pairs its CardioFlux Magnetocardiograph with the integrated Faraday An...

Human Drugs

CDERs Clin/Pharm Office Outlines Priorities

CDERs Office of Clinical Pharmacology (OCP) says that in 2019 it will focus on current health issues related to the opioid epidemic, antimicrobial res...

Federal Register

Antimicrobial Drugs Advisory Committee Meeting on Bacitracin

Federal Register notice: FDA announces a 4/26 Antimicrobial Drugs Advisory Committee meeting to discuss the safety and effectiveness of bacitracin for...

Human Drugs

Safety Alert on AbbVie/Genentechs Venclexta Study

FDA issues a safety alert on the investigational use of AbbVie/Genentechs Venclexta (venetoclax) for treating patients with multiple myeloma based on ...

Human Drugs

FDA Complete Response on Lexicon/Sanofi Diabetes Drug

FDA issues Lexicon Pharmaceuticals and Sanofi a complete response letter on their NDA for investigational Zynquista (sotagliflozin), a dual SGLT1 and ...

Human Drugs

FDA Rejects IV Pain Drug from Recro Pharma

FDA issues Recro Pharma a complete response letter for intravenous meloxicam for managing moderate to severe pain.

Federal Register

Workshop on Nontuberculous Mycobacterial Disease Drugs

Federal Register notice: FDA announces a 4/8 public workshop entitled Development of Antibacterial Drugs for the Treatment of Nontuberculous Mycobacte...

Human Drugs

Researcher May Solve Triple Negative Breast Cancer

Researchers say they have found a way to use a nano-bomb to potentially treat triple negative breast cancer.